ArticleScientific reports2026

Foslevodopa-Foscarbidopa subcutaneous infusion in Parkinson's disease: a cross-cultural/cross-racial international multicentre comparative tolerability study (CRIM-FOS study).

Vinod Metta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.